> On Dec 31, 2015, at 8:48 AM, raghu <[email protected]> wrote: > > On Thu, Dec 31, 2015 at 7:58 AM, Louis Proyect <[email protected]> wrote: > Leukemia patient Michele Steele ’s doctor prescribed Imbruvica last year > after she finished her fourth round of chemotherapy. Though shocked at > the nearly $8,000 out-of-pocket expense for the year, [...] > > [...] But it turned out the couple’s combined income of around $82,000 was > just below the cutoff point. > > > I will take a contrarian view on this that is sure to be hated by my PEN-L > audience. > > Anyone who thinks that being forced to pay $8000 out of a $82,000 income to > treat a life-threatening disease is a great human tragedy really needs to go > out more. > -raghu.
This is certainly a contrarian - and wrongheaded - view. It’s common knowledge that most of that $8000 is pure profit for the drug companies who spend more on marketing than on research and development. http://www.who.int/trade/glossary/story073/en/ The three major industries urgently crying out for public ownership are energy, finance, and pharmaceuticals. _______________________________________________ pen-l mailing list [email protected] https://lists.csuchico.edu/mailman/listinfo/pen-l
